XML 26 R19.htm IDEA: XBRL DOCUMENT v3.25.2
Stockholders' Equity
6 Months Ended
Jun. 29, 2025
Stockholders' Equity Note [Abstract]  
Stockholders' Equity

Note 10. Stockholders’ Equity

Stock Repurchases

From time to time, the Company’s Board of Directors has authorized programs under which the Company may repurchase shares of its common stock, depending on market conditions, in the open market or through privately negotiated transactions. Under the authorizations, the timing and actual number of shares subject to repurchase are at the discretion of management and are contingent on a number of factors, such as levels of cash generation from operations, cash requirements for acquisitions and the price of the Company’s common stock. During the six months ended June 29, 2025 and June 30, 2024, the Company repurchased, retired and reported, based on trade date, approximately 0.5 million and 1.6 million shares of

common stock, at a cost of approximately $15.0 million and $21.4 million, respectively. As of June 29, 2025, approximately 2.8 million shares remained authorized for repurchase under the repurchase program.

The Company repurchased and reported, based on trade date, approximately 370,000 shares and 197,000 shares of common stock, at a cost of approximately $9.7 million and $2.9 million, during the six months ended June 29, 2025 and June 30, 2024, respectively, to administratively facilitate the withholding and subsequent remittance of personal income and payroll taxes for individuals receiving RSUs.

These shares were retired upon repurchase. The Company’s policy related to repurchases of its common stock is to charge the excess of cost over par value to retained earnings. All repurchases were made in compliance with Rule 10b-18 under the Securities Exchange Act of 1934, as amended.

Accumulated Other Comprehensive Income (Loss)

The following tables set forth the changes in accumulated other comprehensive income (loss) (“AOCI”) by component:

 

(In thousands)

 

Unrealized gains (losses)
on available
-for-sale
investments

 

 

Unrealized
gains (losses)
on derivatives

 

 

Estimated tax benefit (provision)

 

 

Total

 

Balance as of December 31, 2024

 

$

169

 

 

$

79

 

 

$

(7

)

 

$

241

 

Other comprehensive income (loss) before reclassifications

 

 

(134

)

 

 

(985

)

 

 

196

 

 

 

(923

)

Less: Amount reclassified from accumulated other comprehensive income (loss)

 

 

 

 

 

(820

)

 

 

172

 

 

 

(648

)

Net current period other comprehensive income (loss)

 

 

(134

)

 

 

(165

)

 

 

24

 

 

 

(275

)

Balance as of June 29, 2025

 

$

35

 

 

$

(86

)

 

$

17

 

 

$

(34

)

 

 

 

 

 

 

 

 

 

 

 

 

 

(In thousands)

 

Unrealized gains (losses)
on available
-for-sale
investments

 

 

Unrealized
gains (losses)
on derivatives

 

 

Estimated tax
benefit (provision)

 

 

Total

 

Balance as of December 31, 2023

 

$

126

 

 

$

7

 

 

$

3

 

 

$

136

 

Other comprehensive income (loss) before reclassifications

 

 

(219

)

 

 

(186

)

 

 

37

 

 

 

(368

)

Less: Amount reclassified from accumulated other comprehensive income (loss)

 

 

 

 

 

(162

)

 

 

34

 

 

 

(128

)

Net current period other comprehensive income (loss)

 

 

(219

)

 

 

(24

)

 

 

3

 

 

 

(240

)

Balance as of June 30, 2024

 

$

(93

)

 

$

(17

)

 

$

6

 

 

$

(104

)

 

The following table provides details about significant amounts reclassified out of each component of AOCI:

 

 

 

Three Months Ended

 

 

Six Months Ended

 

(In thousands)

 

June 29, 2025

 

 

June 30, 2024

 

 

June 29, 2025

 

 

June 30, 2024

 

Amount Reclassified from AOCI

 

 

 

 

 

 

 

 

 

 

 

 

Gains (losses) on cash flow hedge:

 

Foreign currency forward contracts

 

 

 

 

 

 

 

 

 

 

 

 

Affected line item in the statement of operations

 

 

 

 

 

 

 

 

 

 

 

 

Net revenue

 

$

(542

)

 

$

(130

)

 

$

(1,064

)

 

$

(209

)

Cost of revenue

 

 

3

 

 

 

 

 

 

3

 

 

 

 

Research and development

 

 

20

 

 

 

(1

)

 

 

52

 

 

 

(2

)

Sales and marketing

 

 

71

 

 

 

33

 

 

 

150

 

 

 

42

 

General and administrative

 

 

10

 

 

 

(1

)

 

 

39

 

 

 

7

 

Total before tax

 

 

(438

)

 

 

(99

)

 

 

(820

)

 

 

(162

)

Tax impact

 

 

92

 

 

 

21

 

 

 

172

 

 

 

34

 

Total, net of tax

 

$

(346

)

 

$

(78

)

 

$

(648

)

 

$

(128

)